Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway

References

• Choi Y, Bowman JW, Jung JU. Autophagy during viral infection - a double-edged sword. Nat Rev Microbiol. 2018;16(6):341–354.
   PubMed Web of Science ®Google Scholar
• Yeganeh B, Ghavami S, Rahim MN, et al. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochim Biophys Acta Mol Cell Res. 2018;1865(2):364–378.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Mutawe MM, Schaafsma D, et al. Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2012;302(4):L420–428.
   PubMed Web of Science ®Google Scholar
• Mehrbod P, Ande SR, Alizadeh J, et al. The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence. 2019;10(1):376–413.
   PubMed Web of Science ®Google Scholar
• Mao J, Lin E, He L, et al. Autophagy and Viral Infection. Adv Exp Med Biol. 2019;1209:55–78.
   PubMed Web of Science ®Google Scholar
• Habtemariam S, Nabavi SF, Ghavami S, et al. Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the transmembrane serine protease 2. Pharmacol Res. 2020;157:104853.
   PubMed Web of Science ®Google Scholar
• Moradian N, Ochs HD, Sedikies C, et al. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med. 2020;18(1):205.
   PubMed Web of Science ®Google Scholar
• Rehman SU, Shafique L, Ihsan A, et al. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020;9(3):240.
   PubMed Web of Science ®Google Scholar
• Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2020. doi:https://doi.org/10.1016/j.jmii.2020.03.022
   PubMedGoogle Scholar
• Fung TS, Liu DX. Human coronavirus: host-pathogen interaction. Annu Rev Microbiol. 2019;73:529–557.
   PubMed Web of Science ®Google Scholar
• Prentice E, Jerome WG, Yoshimori T, et al. Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem. 2004;279(11):10136–10141.
   PubMed Web of Science ®Google Scholar
• Cottam EM, Whelband MC, Wileman T. Coronavirus NSP6 restricts autophagosome expansion. Autophagy. 2014;10(8):1426–1441.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang K, Xing Y, et al. Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity. Protein Cell. 2014;5(12):912–927.
   PubMed Web of Science ®Google Scholar
• Gassen NC, Niemeyer D, Muth D, et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019;10(1):5770.
   PubMed Web of Science ®Google Scholar
• Reggiori F, Monastyrska I, Verheije MH, et al. Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe. 2010;7(6):500–508.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Thackray LB, Miller BC, et al. Coronavirus replication does not require the autophagy gene ATG5. Autophagy. 2007;3(6):581–585.
   PubMed Web of Science ®Google Scholar
• Benvenuto D, Angeletti S, Giovanetti M, et al. Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy. J Infect. 2020;81(1):e24-e27.
   PubMed Web of Science ®Google Scholar
• Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–1379.
   Web of Science ®Google Scholar
• WHO; 2020. Table of therapeutics against COVID-19 as 21st March 2020 WHO. Available from: https://www.who.int/blueprint/priority-diseases/key-action/Table_of_therapeutics_Appendix_17022020.pdf?ua=1
   Google Scholar
• Shojaei S, Koleini N, Samiei E, et al. Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. Febs J. 2020;287(5):1005–1034.
   PubMed Web of Science ®Google Scholar
• Fung TS, Huang M, Liu DX. Coronavirus-induced ER stress response and its involvement in regulation of coronavirus–host interactions. Virus Res. 2014;194:110–123.
   PubMed Web of Science ®Google Scholar
• Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol. 2014;5:296.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Sharma P, Yeganeh B, et al. Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochim Biophys Acta. 2014;1843(7):1259–1271.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Yeganeh B, Zeki AA, et al. Autophagy and the unfolded protein response promote profibrotic effects of TGF-beta1 in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2018;314(3):L493–L504.
   PubMed Web of Science ®Google Scholar
• Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem. 2007;282(28):20047–20051.
   PubMed Web of Science ®Google Scholar
• Nabirotchkin S, Peluffo AE, Bouaziz J, et al. Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19, MDPI Priprint, 2020
   Google Scholar
• Edelstein CL, Venkatachalam MA, Dong Z. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect AKI and other organ injury in critically ill patients with COVID-19. Kidney Int. 2020. doi:https://doi.org/10.1016/j.kint.2020.05.001
   Google Scholar
• Pereira BB. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2020 (COVID-19) pandemic: a timely review. J Toxicol Environ Health B Crit Rev. 2020;18;23(4):177-181. doi:https://doi.org/10.1080/10937404.2020.1752340
   Google Scholar
• Pahan P, Pahan K. Smooth or risky revisit of an old malaria drug for COVID-19? J Neuroimmune Pharmacol. 2020;15(2):174–180.
   PubMed Web of Science ®Google Scholar
• Yang N, Shen HM. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci. 2020;16(10):1724–1731.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.
   PubMed Web of Science ®Google Scholar
• Labouta HI, Menina S, Kochut A, et al. Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery. J Control Release. 2015;220(Part A):414–424.
   PubMedGoogle Scholar
• Labouta HI, El-Khordagui LK, Kraus T, et al. Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale. 2011;3(12):4989–4999.
   PubMed Web of Science ®Google Scholar
• Castoldi A, Herr C, Niederstraßer J, et al. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm. 2017;118:62–67.
   PubMed Web of Science ®Google Scholar
• Labouta HI, Gomez-Garcia MJ, Sarsons CD, et al. Surface-grafted polyethylene glycol conformation impacts the transport of PEG-functionalized liposomes through a tumour extracellular matrix model. RSC Adv. 2018;8(14):7697–7708.
   PubMed Web of Science ®Google Scholar
• Cordani M, Somoza Á. Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment. Cell Mol Life Sci. 2019;76(7):1215–1242.
   PubMed Web of Science ®Google Scholar
• Singh L, Kruger HG, Maguire GEM, et al. The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis. 2017;4(4):105–131.
   PubMed Web of Science ®Google Scholar
• Chan WCW. Nano research for COVID-19. ACS Nano. 2020;14(4):3719–3720.
   Web of Science ®Google Scholar
• Hu TY, Frieman M, Wolfram J. Insights from nanomedicine into chloroquine efficacy against COVID-19. Nat Nanotechnol. 2020;15(4):247–249.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435–1455.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier E, Dorner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155–166.
   PubMed Web of Science ®Google Scholar
• Kyrmizi I, Gresnigt MS, Akoumianaki T, et al. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 2013;191(3):1287–1299.
   PubMed Web of Science ®Google Scholar
• Langhammer A, Forsmo S, Syversen U. Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis. 2009;4:365–380.
   PubMedGoogle Scholar
• Rodriguez M, Lapierre J, Ojha CR, et al. Morphine counteracts the antiviral effect of antiretroviral drugs and causes upregulation of p62/SQSTM1 and histone-modifying enzymes in HIV-infected astrocytes. J Neurovirol. 2019;25(2):263–274.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Thangaraj A, Chivero ET, et al. Antiretroviral-mediated microglial activation involves dysregulated autophagy and lysosomal dysfunction. Cells. 2019;8(10):1168.
   Web of Science ®Google Scholar
• Stravitz RT, Shiffman ML, Kimmel M, et al. Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. Liver Int. 2012;32(7):1138–1145.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wang ML, Li Z, et al. Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway. Cancer Biol Med. 2014;11(1):64–68.
   PubMedGoogle Scholar
• Hejny C, Sternberg P, Lawson DH, et al. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol. 2001;131(6):782–787.
   PubMed Web of Science ®Google Scholar
• Zha BS, Wan X, Zhang X, et al. HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes. PLoS One. 2013;8(3):e59514.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim SW, Chang HH, et al. Comparison of antiretroviral regimens: adverse effects and tolerability failure that cause regimen switching. Infect Chemother. 2015;47(4):231–238.
   PubMed Web of Science ®Google Scholar
• Ishida S, Akiyama H, Umezawa Y, et al. Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2. Oncotarget. 2018;9(42):26834–26851.
   PubMedGoogle Scholar
• Kusoglu A, Bagca BG, Ozates Ay NP, et al. Ruxolitinib regulates the autophagy machinery in multiple myeloma cells. Anticancer Agents Med Chem. 2020;20. DOI:https://doi.org/10.2174/1871520620666200218105159
   Google Scholar
• Alimam S, McLornan D, Harrison C. The use of JAK inhibitors for low-risk myelofibrosis. Expert Rev Hematol. 2015;8(5):551–553.
   PubMed Web of Science ®Google Scholar